Preferences for HIV Pre-Exposure Prophylaxis Products and Delivery Models Among Cisgender Men, Transgender Persons, and Nonbinary Individuals Who Have Sex With Men in Seattle, Washington: A Discrete Choice Experiment
Participants preferred products with high efficacy and longer dosing intervals delivered in nonclinical spaces with in-person or online follow-up appointments. These data suggest that, although highly efficacious, longer acting products are preferred, a range of different modalities, prescribers, and monitoring methods may be needed to reach everyone who may benefit from PrEP.
Authors
- Lauren R. Violette (ORCID: https://orcid.org/0000-0001-6469-7298)
- Chase A. Cannon (ORCID: https://orcid.org/0000-0002-2962-754X)
- Lisa A. Niemann (ORCID: https://orcid.org/0000-0002-3295-8921)
- Joanne D. Stekler (ORCID: https://orcid.org/0000-0001-8064-3011)
- David A. Katz (ORCID: https://orcid.org/0000-0002-7786-0194)
- Jakar Delacruz
Institutions
- Public Health – Seattle & King County (US)
- Harvard University (US)
- University of Washington (US)
- Harvard Pilgrim Health Care (US)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1097/qai.0000000000003718
- Primary Topic
- Economic and Environmental Valuation
- Type
- article
- Field-Weighted Citation Impact
- 0.00